Table of Contents
CBD can raise warfarin levels by slowing the liver enzyme that clears it, which may push your INR above its target range and raise bleeding risk. The evidence is thin — mostly case reports — but real enough that doctors take it seriously. If you take warfarin, talk to your doctor before trying CBD.
Why does warfarin need such careful balance?
Warfarin is a blood thinner prescribed to prevent clots — after a mechanical heart valve replacement, for example, or with certain heart rhythm problems. It works by slowing your blood’s ability to clot, and the dose has to sit in a narrow sweet spot. Too little, and clots can form. Too much, and you can bleed more than you should. That sweet spot is tracked with a blood test called the INR, short for international normalized ratio.
For many people on warfarin, the target INR range is 2 to 3. Your clinic checks it regularly and adjusts your dose to stay inside that range. A new medicine, a big change in diet, even an illness can move your INR — which is why warfarin comes with more monitoring than most prescriptions.
That narrow margin is why CBD deserves a second thought. CBD isn’t a blood thinner itself, but it can change how much warfarin stays in your system — and with warfarin, a little extra can matter a lot.
How could CBD get in the way?
Your liver clears warfarin using a family of enzymes called cytochrome P450. The most important one for warfarin is CYP2C9, which breaks down S-warfarin — the more active of warfarin’s two forms. CBD inhibits CYP2C9, meaning it slows that enzyme down. When the enzyme slows, S-warfarin hangs around longer and at higher levels than your prescribed dose was meant to produce.
The FDA prescribing information for Epidiolex, the only FDA-approved CBD medicine, documents CBD’s effects on these liver enzymes, and it lists warfarin among the medicines that should be monitored when taken alongside CBD. That’s a useful reality check: this isn’t a rumor from internet forums. The interaction is written into the label of the one CBD product the FDA has actually approved.
One wrinkle worth knowing: Epidiolex is pharmaceutical-grade CBD, given in known doses under a doctor’s eye. Most CBD on store shelves isn’t. Over-the-counter oils, gummies, and capsules vary in strength, and some contain more (or less) CBD than the label says. So the tidy, monitored picture from the Epidiolex label doesn’t map neatly onto a bottle you picked up yourself — which is one more reason to loop your doctor in rather than guessing.
The case report that put this on the map
The best-known report comes from Grayson and colleagues, published in 2018. It followed a 44-year-old man with Marfan syndrome who had a mechanical mitral valve replacement and took warfarin for it. His INR had been stable between 2.0 and 2.6 for at least six months on 7.5 mg of warfarin a day. Then he started prescription CBD (Epidiolex) for epilepsy, beginning at 5 mg/kg per day and increasing in steps every two weeks under medical supervision.
As the CBD dose climbed, his INR climbed with it — at one point reaching 6.86, far above his 2 to 3 target. His doctors kept lowering his warfarin dose to compensate, and by the end of the report it had been cut by roughly 30%, down to about 5.36 mg a day. The authors concluded that patients on warfarin who start CBD need closer INR monitoring, and they suggested checking INR when CBD is started and whenever its dose changes.
Keep this in perspective: one patient, in a supervised epilepsy program, taking pharmaceutical CBD at doses that climbed over months. It’s a warning light, not a prediction — proof the interaction can happen and can be large, not that it will play out the same way for everyone.
What does the rest of the evidence say?
A 2023 systematic review in Pharmacotherapy pulled together everything published on cannabinoids and blood thinners. The authors found just seven case reports about warfarin — and nothing else. In six of the seven, INR rose after the person started a cannabis or CBD product. The biggest reported INR jumps ranged from +0.4 to +9.61, and one of the seven reports involved bleeding.
But the authors rated the overall evidence as very low quality, and for good reason. The cannabis or CBD doses in those cases were either unknown or very high — over 600 mg of CBD a day in some reports. That’s far above a typical store-bought dose, so these cases say little about everyday use. The review’s bottom line: a real interaction with warfarin is plausible and worth watching for, but the evidence is thin and mostly comes from unusual situations.
There’s a second gap in the evidence that’s easy to miss. The same review found no published evidence of an interaction between cannabinoids and newer blood thinners like apixaban or rivaroxaban. That doesn’t mean those combinations are safe — it means nobody has published good data on them either way. If you take a newer anticoagulant, “no case reports” is not the same as “no risk.”
What about other blood thinners?
Warfarin is the one with published patient cases behind it, so it gets most of the attention. For the newer direct oral anticoagulants — apixaban (Eliquis), rivaroxaban (Xarelto), and similar drugs — the picture is murkier. They don’t rely on CYP2C9 the way warfarin does, and they don’t use INR monitoring, so the same warning signs wouldn’t show up the same way. But CBD also affects other liver enzymes, including CYP3A4, which plays a role in clearing some of these drugs.
So the practical advice doesn’t really change: if you take any prescription blood thinner and you’re thinking about CBD, your prescriber or pharmacist should hear about it first. They can look at your specific medicine, your dose, and your other prescriptions, and decide whether any extra checks make sense. A quick chat beats a surprise lab result.
If you’re thinking about CBD, what should you actually do?
Here’s the short version: don’t mix first and ask later. A few practical steps can keep this simple.
- Tell your doctor or pharmacist before you start. The clinician who manages your warfarin and INR is the right person — not a shop assistant, and not a label. Mention the product, the strength, and how you plan to take it.
- Don’t stop your warfarin to make room for CBD. Stopping a blood thinner suddenly can leave you exposed to clots. If any change is needed, it’s your prescriber’s call, not a do-it-yourself adjustment.
- Don’t quietly adjust your own warfarin dose. In the published cases, dose changes were made by doctors, guided by INR tests. Guessing at a lower dose because you started CBD is a gamble with the same risks the monitoring is meant to catch.
- Remember that stopping CBD counts as a change too. If your body has adjusted to CBD slowing that liver enzyme, stopping it can shift things back. Mention it if you quit, just as you would if you started.
- Bring the product with you. A photo of the label, or the bottle itself, helps your pharmacist see the strength and ingredients. With CBD, what the bottle says and what’s inside don’t always match — and if you’re also curious about how CBD interacts with metabolism more broadly, that’s a good conversation starter too.
And if you’re still weighing whether CBD is worth it for you at all, it helps to know the basics first — our guide to CBD delivery methods and how to take CBD walks through oils, capsules, gummies, and topicals, and what makes them different. None of that changes the warfarin conversation, but it does mean you’ll walk into the doctor’s office knowing what you’re actually asking about.
Warning signs worth acting on fast
Whatever you decide, know what a too-high INR can look like: unusual bruising, nosebleeds that won’t stop, bleeding gums, blood in your urine or stool, or a severe headache. Those are reasons to get medical help promptly — and to mention both your warfarin and any CBD you’ve used. Don’t wait for your next routine INR check if something feels off.
This is general information, not medical advice — if you take warfarin or any blood thinner, talk to your doctor before trying CBD. You can read our full medical disclaimer for more detail.
Frequently asked questions
Can I take CBD while on warfarin?
Only with your doctor’s knowledge. Case reports show CBD can raise INR and bleeding risk by slowing the enzyme that clears warfarin, and doctors in those cases lowered warfarin doses by up to about 30%. Never mix the two without telling the clinician who manages your INR first.
Does the type of CBD matter — oil, gummy, or cream?
It may affect how much CBD reaches your bloodstream, but no published study compares INR effects across product types. Oils and capsules are swallowed and processed by the liver, while creams mostly act where you put them. Treat any CBD product as worth mentioning to your doctor, whatever form it takes.
How quickly could CBD affect my INR?
There’s no fixed timeline. In the best-known case report, INR rose gradually as the CBD dose was increased step by step over weeks. Your doctor decides when to recheck your INR — the point is to have a monitoring plan in place before you start, not to guess at a safe window yourself.
What if I already started CBD without telling my doctor?
Tell them now — it’s never too late for that conversation, and they won’t be shocked. Don’t stop your warfarin on your own, and don’t change its dose to compensate. Bring the product label, say how much you’ve been taking, and let them decide whether an INR check is needed.
Are newer blood thinners like apixaban safer with CBD?
We don’t know. A 2023 systematic review found no published evidence of cannabinoid interactions with newer blood thinners — but absence of evidence isn’t proof of safety. These drugs use different liver pathways than warfarin, so the risk may differ. Ask your prescriber or pharmacist about your specific medicine before assuming it’s fine.
Keep exploring
If you want more background, our CBD Guides hub collects our CBD explainers in one place. And if you’re curious about how CBD affects the body beyond drug interactions, our look at whether CBD can help or hurt fatty liver disease is a good next read — the liver sits at the center of both stories.
Affiliate Disclosure
The CakeHeights Editorial Team is committed to providing accurate, research-backed information about cannabis and hemp products. Some links on this page are affiliate links, meaning we may earn a commission at no extra cost to you if you make a purchase through them. Our recommendations are based on independent research, testing, and analysis. We only promote products we believe offer genuine value to our readers. Learn more →